PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Oxymetazoline hydrochloride
Presentation Product Chemical substance Chapter Items dispensed
Oxymetazoline 0.05% nasal spray
1202020G0AAAAAA
Oxymetazoline Oxymetazoline hydrochloride Ear, Nose and Oropharynx 1
Afrazine 0.05% nasal spray
1202020G0BBAAAA
Afrazine Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Boots Blocked Nose Relief 0.05% nasal spray
1202020G0BFAAAA
Boots (Nasal spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Care Decongestant 0.05% nasal spray
1202020G0BIAAAA
Care (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Galpharm Blocked Nose Relief 0.05% nasal spray
1202020G0BGAAAA
Galpharm (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Galpharm Cold & Flu Decongestant 0.05% nasal spray
1202020G0BGABAA
Galpharm (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Galsud Decongestant 0.05% nasal spray
1202020G0BHAAAA
Galsud (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Lemsip Max Sinus All Night Decongestant 0.05% nasal spray
1202020G0BEAAAA
Lemsip (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Numark Nasal Decongestant 0.05% spray
1202020G0BJAAAA
Numark (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Vicks Sinex Decongestant nasal spray
1202020G0BCAAAA
Vicks (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available
Vicks Sinex Micromist nasal spray
1202020G0BCABAA
Vicks (Nasal Spray) Oxymetazoline hydrochloride Ear, Nose and Oropharynx No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.